EGF Theramed Health Corp.
EVAHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.09 | 0.09 | 0.00 |
| FCF Yield | 2.42% | -0.01% | -11.68% | -3,255.61% |
| EV / EBITDA | -1.17 | 0.00 | -11.04 | -1.24 |
| Quality | ||||
| ROIC | 8.40% | 24.15% | 53.08% | 89.86% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.01 | 0.50 | 0.92 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 16,406.72% | 99.98% | 42.02% | -26.75% |
| Safety | ||||
| Net Debt / EBITDA | -0.64 | 0.00 | -2.34 | -1.21 |
| Interest Coverage | -4.18 | -8.29 | -16.11 | -69.15 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |